FindTrial
Sign In

PF-05175157

DRUG11 trials

Sponsors

Pfizer

Conditions

Acne VulgarisDiabetes MellitusDiabetes Mellitus Type 2Diabetes Mellitus, Type 2Glucose Metabolism DisordersHealthyType 2 Diabetes Mellitus

Phase 1

A Study To Evaluate PF-05175157 In Healthy Volunteers
CompletedNCT01433380
PfizerDiabetes Mellitus, Type 2
Start: 2011-07-31End: 2012-05-31Updated: 2012-05-18
A Study To Estimate The Effect Of Repeated Dosing of PF-05175157 On The Pharmacokinetics Of A Single Dose Of Simvastatin In Healthy Adult Subjects
CompletedNCT01469468
PfizerType 2 Diabetes Mellitus
Start: 2011-11-30End: 2011-12-31Updated: 2018-11-14
A Study To Evaluate The Effects Of PF-05175157 In Healthy Volunteers
CompletedNCT01537497
PfizerDiabetes Mellitus, Type 2
Start: 2012-03-31End: 2012-05-31Updated: 2012-07-10
Multiple Dose Safety Toelrability, Pharmacokinetics and Midazolam Interaction In Healthy Overweight And Obese Subjects
CompletedNCT01757756
PfizerDiabetes Mellitus, Diabetes Mellitus, Type 2, Glucose Metabolism Disorders
Start: 2012-10-31End: 2012-11-30Updated: 2012-12-31
Multiple Dose Safety Tolerability, Pharmacokinetics And Midazolam Interaction In Healthy Overweight And Obese Subjects
CompletedNCT01807377
PfizerDiabetes Mellitus Type 2
Start: 2013-04-30End: 2013-08-31Updated: 2013-09-17
Effect Of Single-Dose PF-05175157 On Metabolic And Cardiopulmonary Parameters
CompletedNCT01819922
PfizerHealthy
Start: 2013-04-30End: 2013-10-31Updated: 2016-05-02
A Healthy Volunteer Study To Assess Relative Bioavailability Of Powder-In-Capsule And A Tablet Formulation And The Effect Of Food On The Pharmacokinetics Of The Tablet Formulation
CompletedNCT01821079
PfizerHealthy
Start: 2013-03-31End: 2013-04-30Updated: 2013-05-21

Phase 2

A 6-Week Study Of PF-05175157 In Type 2 Diabetes Mellitus
TerminatedNCT01792635
PfizerDiabetes Mellitus, Type 2
Start: 2012-12-31End: 2014-05-31Updated: 2017-02-16
A 6-Week Study To Determine The Safety And Effect Of An Investigational Drug On Adults With Type 2 Diabetes Mellitus Taking Metformin
TerminatedNCT02053103
PfizerType 2 Diabetes Mellitus
Start: 2014-03-31End: 2014-04-30Updated: 2016-05-02
A 6-Week Study To Determine The Safety And Effect Of An Investigational Drug Given With Canagliflozin In Adults With Type 2 Diabetes Mellitus Taking Metformin
TerminatedNCT02053116
PfizerType 2 Diabetes Mellitus
Start: 2014-03-31End: 2014-04-30Updated: 2016-05-02
Study Of Safety, Tolerability And Effects Of PF-05175157 In Adults With Moderate To Severe Acne Vulgaris
WithdrawnNCT02100527
PfizerAcne Vulgaris
Start: 2014-04-30End: 2014-10-31Updated: 2014-05-13